What's New
Front Page
AFTD News: Fall 2020, Vol. 17, Issue 3
In this issue: AFTD to Host Patient-Focused Drug Development Meeting with FDA; A Week of Awareness…; Spotlight…
Perspectives in FTD Research Webinar: Gene Therapy in FTD
Gene therapy is showing promise for treating a wide range of diseases, and related clinical trials…
Wash. Post Reports on FTD and Other Atypical Dementias
People in their 50s and 60s are increasingly being diagnosed with non-Alzheimer’s forms of dementia, including frontotemporal…
Watch the 2020 World FTD Marathon…
The first-ever World FTD Marathon, a day-long series of interactive webinars from around the globe, is now…
Webinar: Living the Grief of FTD – The Winding Paths of Loss, Love, and Resilience
In FTD, losses begin with the first presenting symptoms. Even before a diagnosis, persons diagnosed and their…
Webinar: FTD and Genetic Testing – A Practical Approach
About 40% of people affected by FTD have a family history with at least one other relative…
When the Conversation Stops: Logopenic Variant Primary Progressive Aphasia
Partners in FTD Care, Fall 2020 Download the full issue (pdf) Primary progressive aphasia (PPA) is a neurodegenerative…
AFTD-Backed Research Offers Insights into C9orf72 Protein Structure
New AFTD-funded research published in Nature provides important insights into the structure of the C9orf72 protein, which…
Alabama Family Shares FTD Journey, Speaks to Importance of Connection
Although FTD has robbed Gene Guy of the ability to talk, he still communicates with his daughter,…
AFTD and ADDF Announce Major New Investments in FTD Research
AFTD and The Alzheimer’s Drug Discovery Foundation (ADDF) announced today four new research awards to scientists looking…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)